Roivant Sciences ROIV
NASDAQ ROIV
$42.01 +0.53 (+1.28%)
As of: Sep 9, 2026 · 1:27 PM EDT

Roivant Sciences (ROIV) Exchange Rate Effect (2023 - 2026)

Roivant Sciences' (ROIV) quarterly Exchange Rate Effect came in at $315000.0 in Q2 2026, down 61.35% on a YoY basis from $815000.0 in Q2 2025, and down 87.15% quarter-over-quarter from $2.5 million in Q4 2025.

Analysis

Roivant Sciences (ROIV) Exchange Rate Effect (2023 - 2026) Analysis & Trends

Roivant Sciences (ROIV) has reported Exchange Rate Effect for 4 consecutive years, with $315000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Exchange Rate Effect fell 61.35% year-over-year to $315000.0; the trailing twelve-month figure through Jun 2026 stood at $4.8 million (up 9.94% YoY), and the FY2026 full-year result was $3.8 million, up 404.28% from the prior year.
  • Exchange Rate Effect declined to $315000.0 in Q2 2026 per ROIV's latest filing, from $2.5 million in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $5.0 million in Q3 2024 and bottomed at -$2.7 million in Q2 2024.
  • Historically, Exchange Rate Effect has averaged $822600.0 across 4 years, with a median of $1.0 million in 2025.
  • The widest YoY moves for Exchange Rate Effect: up 446.84% in 2024, down 2241.88% in 2024.
  • Over 4 years, Exchange Rate Effect stood at $1.5 million in 2023, then dropped by 15.98% to $1.2 million in 2024, then surged by 98.3% to $2.5 million in 2025, then tumbled by 87.15% to $315000.0 in 2026.
  • According to Business Quant data, Exchange Rate Effect over the past three periods registered $315000.0, $2.5 million, and $1.2 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Amgen 211.21 Bn 197.22 Bn 7.24 Bn -
2 Gilead Sciences 181.48 Bn 178.31 Bn 6.22 Bn -19.00 Mn
3 Vertex Pharmaceuticals 132.31 Bn 124.46 Bn 2.84 Bn -3.70 Mn
4 Regeneron Pharmaceuticals 82.80 Bn 74.80 Bn 3.93 Bn -300,000.00
5 Argenx Se 61.62 Bn 56.43 Bn 1.37 Bn -
6 Moderna 54.72 Bn 49.58 Bn 52.00 Mn -2.00 Mn
7 Alnylam Pharmaceuticals 34.15 Bn 30.84 Bn 992.69 Mn -2.45 Mn
8 Biogen 31.30 Bn 30.02 Bn 1.96 Bn -3.40 Mn
9 Roivant Sciences 30.28 Bn 30.28 Bn 1.16 Mn 315,000.00
10 Insmed 28.21 Bn 27.05 Bn 358.27 Mn -287,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 315,000.00
Dec 31, 2025 2.45 Mn
Sep 30, 2025 1.21 Mn
Jun 30, 2025 815,000.00
Dec 31, 2024 1.24 Mn
Sep 30, 2024 5.04 Mn
Jun 30, 2024 -2.74 Mn
Dec 31, 2023 1.47 Mn
Sep 30, 2023 -1.45 Mn
Jun 30, 2023 -117,000.00